Cancer researchers’ finding sheds light on COVID immunity


Vaccination campaigns are running worldwide in an attempt to end the COVID-19 pandemic. In the ideal case, the current vaccines will ban SARS-CoV-2 completely. But what if we need new vaccines after a while, because of viral mutations? Researchers from the Netherlands Cancer Institute have identified new viral targets that can potentially help to develop new vaccines. They also contribute to a better understanding of the immune response against SARS-CoV-2.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.